To characterize the recurrence of bleeding in patients who had hypertensive
intracerebral hemorrhage (HICH), the authors reviewed 989 patients who und
erwent treatment for HICH between 1989 and 1995. Fifty-three patients (5.4%
) had two episodes of HICH within a median interval of 22.9 +/- 16.3 months
(range 1.5-72 months), and of these 3 (5.7%) had three episodes of HICH. T
he recurrence of breeding most commonly occurred within 2 years of the firs
t hemorrhage: in 66% of the 53 patients the second hemorrhage occurred soon
after the first (within 1 year in 34%, within 1-2 years in 32.1%). The sit
e of the second hemorrhage was different from the initial site in all patie
nts. Only 1 patient had a third hemorrhage in the same site as the second h
emorrhage. The common patterns of recurrence were 'ganglionic (putamen/caud
ate nucleus)-thalamic' in 26.8% and 'ganglionic-ganglionic' in 21.4%. The '
lobar-lobar' pattern was noted in only 2 patients. The volume of the hemato
ma was increased at the second hemorrhage. The overall mortality was 28.3%.
The risk of recurrent hemorrhage significantly increased in the patients w
ho had antihypertensive therapy of less than 3 months after the initial att
ack compared to those with further long-term therapy (p < 0.005). Long-term
regular control for hypertension is needed to prevent recurrent hemorrhage
.